Xlife Sciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	119	142	146	279	157	-
Market Cap Growth	-20.41%	-2.32%	-47.72%	77.76%	-	-
Enterprise Value	264	290	295	434	321	-
Last Close Price	20.60	24.70	25.40	49.90	29.70	-
PE Ratio	-	-	4.26	18.75	10.97	-
PS Ratio	431.55	517.45	174.69	282.22	152.66	-
PB Ratio	0.32	0.38	0.37	0.76	0.47	-
P/TBV Ratio	3.62	4.34	4.04	-	-	-
P/FCF Ratio	-	-	-	1766.87	-	-
P/OCF Ratio	-	-	-	1623.87	-	-
EV/Sales Ratio	-	1053.24	353.76	439.10	311.96	-
EV/FCF Ratio	-206.71	-	-	2749.02	-	-
Debt / Equity Ratio	0.16	0.16	0.15	0.16	0.18	0.20
Debt / FCF Ratio	-	-	-	359.14	-	-
Net Debt / Equity Ratio	0.16	0.16	0.15	0.16	0.18	0.19
Net Debt / EBITDA Ratio	-18.43	-18.43	-17.46	-12.88	-11.92	-11.83
Net Debt / FCF Ratio	-46.23	-46.23	-136.58	357.75	-13.07	-13.73
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	7.13	7.13	-	-	-	-
Quick Ratio	0.10	0.10	1.53	3.11	0.61	1.05
Current Ratio	0.10	0.10	1.54	3.11	0.65	1.06
Return on Equity (ROE)	-7.05%	-7.05%	7.54%	2.64%	2.67%	23.71%
Return on Assets (ROA)	-3.73%	-3.73%	-2.30%	-2.53%	-2.70%	-0.98%
Return on Invested Capital (ROIC)	-7.32%	-7.12%	-4.41%	-4.96%	-5.39%	-1.87%
Return on Capital Employed (ROCE)	-6.30%	-6.30%	-3.60%	-4.00%	-4.30%	-1.10%
Earnings Yield	-18.14%	-15.13%	23.50%	5.33%	9.12%	-
FCF Yield	-1.07%	-0.90%	-0.30%	0.06%	-2.95%	-
Buyback Yield / Dilution	21.59%	21.94%	-1.34%	0.17%	-17.26%	-4.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.